# Mistral-7B vs GPT-4o-mini for Banking Tasks

## Task Complexity Analysis

### Level 1 Banking (Evidence Grading)
**Task**: Assign evidence grade (A/B/C/D) based on comprehensive analysis of multiple research papers

**Input Requirements**:
- Up to 100 research papers per supplement×goal combination
- Each paper: title, abstract/content (up to 2000 chars), study type, quality metrics
- Pre-computed quality metrics (meta-analyses count, RCTs, consistency scores)
- Effect sizes, supporting papers, contradictory papers

**Output**: Single letter grade (A/B/C/D) - highly constrained

**Key Challenges**:
1. **Multi-document synthesis**: Must synthesize information across many papers
2. **Quality assessment**: Distinguish between high-quality (meta-analyses, RCTs) vs low-quality studies
3. **Consistency detection**: Identify when studies agree vs contradict
4. **Effect size interpretation**: Understand clinical significance
5. **Relevance filtering**: Ensure evidence is relevant to specific goal

### Level 2 Banking (Profile-Specific Reasoning)
**Task**: Generate personalized reasoning paragraph (2-3 sentences) with citations

**Input Requirements**:
- Base evidence grade and metrics
- Profile-specific papers (up to 5, 1500 chars each)
- Profile characteristics (weight bin, sex, age bin)
- Goal context

**Output**: Natural language paragraph with citations

**Key Challenges**:
1. **Evidence synthesis**: Combine base evidence with profile-specific findings
2. **Citation accuracy**: Must only cite papers that were actually provided
3. **Natural language generation**: Write coherent, scientifically accurate reasoning
4. **Profile personalization**: Identify relevant findings for specific demographics

---

## Model Comparison

### Mistral-7B-Instruct Performance

#### ✅ **Strengths for Banking**
1. **Structured Output**: Excellent at following constrained output formats (single letter grades)
2. **Instruction Following**: Good at following detailed prompts with criteria
3. **Proven Track Record**: Already successfully used for paper processing (card extraction)
4. **Cost**: $0 per run (local GPU)
5. **Privacy**: On-premise processing

#### ⚠️ **Potential Weaknesses**
1. **Multi-Document Synthesis**: 
   - May struggle with synthesizing 100+ papers simultaneously
   - Context window limitations (8K tokens) may truncate important papers
   - Could miss nuanced patterns across large document sets

2. **Citation Accuracy**:
   - Higher risk of hallucinating citations not in the provided papers
   - May struggle to accurately match evidence to specific papers
   - Could invent paper titles/details

3. **Quality Assessment**:
   - May have difficulty distinguishing subtle quality differences
   - Could overvalue lower-quality studies
   - Might miss important methodological limitations

4. **Consistency Detection**:
   - May struggle to identify contradictions across many papers
   - Could miss nuanced disagreements (e.g., "effective but only at high doses")

5. **Natural Language Generation** (Level 2):
   - Paragraph quality may be less coherent than GPT-4o-mini
   - Could have more grammatical errors or awkward phrasing
   - May struggle with scientific terminology precision

#### 📊 **Expected Performance Estimates**
- **Level 1 (Grading)**: ~85-90% accuracy vs GPT-4o-mini
  - Good at clear cases (strong A/D grades)
  - May struggle with edge cases (B/C grades where nuance matters)
  - Risk of misclassifying 5-10% of combinations

- **Level 2 (Reasoning)**: ~80-85% quality vs GPT-4o-mini
  - Citation accuracy: ~90-95% (vs ~98% for GPT-4o-mini)
  - Coherence: ~85-90% (vs ~95% for GPT-4o-mini)
  - Scientific accuracy: ~85-90% (vs ~95% for GPT-4o-mini)

### GPT-4o-mini Performance

#### ✅ **Strengths**
1. **Multi-Document Synthesis**: Excellent at synthesizing information across many papers
2. **Citation Accuracy**: Very reliable (~98% accuracy), rarely hallucinates citations
3. **Quality Assessment**: Strong at distinguishing study quality and methodology
4. **Consistency Detection**: Good at identifying patterns and contradictions
5. **Natural Language**: High-quality, coherent scientific writing
6. **Speed**: 20-30 minutes with parallel execution

#### ⚠️ **Trade-offs**
1. **Cost**: ~$10.50 per run (with 63 supplements)
2. **Cloud Dependency**: Requires internet and Azure service availability

---

## Risk Analysis

### Critical Risks with Mistral-7B

#### 🔴 **High Risk Areas**
1. **Citation Hallucination**: 
   - Could cite papers that don't exist or weren't provided
   - User-facing content could have incorrect citations
   - **Impact**: Loss of trust, potential legal issues

2. **Grade Misclassification**:
   - Could assign Grade A to supplements with Grade C evidence
   - Could miss safety signals (assign Grade D when should be lower)
   - **Impact**: Misleading recommendations, potential harm

3. **Profile-Specific Errors**:
   - Could generalize findings incorrectly (e.g., "effective for men" when only tested in women)
   - Could miss important demographic-specific considerations
   - **Impact**: Inaccurate personalized recommendations

#### 🟡 **Medium Risk Areas**
1. **Reasoning Quality**:
   - Lower coherence could confuse users
   - Scientific accuracy issues could reduce trust
   - **Impact**: User experience degradation

2. **Edge Cases**:
   - B/C grade assignments where nuance matters
   - Supplements with mixed evidence
   - **Impact**: Some combinations may be less accurate

#### 🟢 **Low Risk Areas**
1. **Clear Cases**:
   - Strong Grade A supplements (creatine, protein)
   - Clear Grade D supplements (weak evidence)
   - **Impact**: Minimal - both models perform well

---

## Validation Strategy (If Using Mistral-7B)

### Phase 1: Parallel Comparison (Recommended)
1. **Run both models** on same banking inputs
2. **Compare outputs**:
   - Grade agreement rate (should be >90%)
   - Citation accuracy (spot-check for hallucination)
   - Reasoning quality (human evaluation)
3. **Identify discrepancies**: Review cases where models disagree
4. **Measure impact**: Check if discrepancies affect user recommendations

### Phase 2: Spot Validation
1. **Sample 10% of combinations** for human expert review
2. **Focus on**:
   - Edge cases (B/C grades)
   - High-importance supplements (creatine, protein, caffeine)
   - Profile combinations with strong demographic differences
3. **Validate citations**: Check that all cited papers exist and were provided

### Phase 3: Production Monitoring
1. **Track user feedback** on recommendations
2. **Monitor citation clicks**: Are users finding the papers?
3. **Compare reasoning quality**: User satisfaction surveys
4. **A/B testing**: Gradually shift traffic to Mistral if quality is acceptable

---

## Recommendation

### Short-Term (Next 3-6 months)
**Stick with GPT-4o-mini** for banking because:
1. **Quality is critical** for health recommendations
2. **Cost is reasonable** (~$42/year quarterly)
3. **Already proven** and working well
4. **Citation accuracy** is essential for trust
5. **Risk mitigation**: Lower risk of errors affecting users

### Medium-Term (6-12 months)
**Consider Mistral-7B** if:
1. **Cost becomes a concern** (if banking runs become monthly/weekly)
2. **Quality validation** shows Mistral meets standards (90%+ grade agreement)
3. **You develop validation infrastructure** to catch errors
4. **You want consistency** with paper processing (same model)

### Validation Path Forward
1. **Create validation script**: Run both models in parallel, compare outputs
2. **Test on 100 combinations**: Sample Level 1 + Level 2
3. **Expert review**: Have domain expert evaluate disagreements
4. **Measure metrics**: Grade agreement, citation accuracy, reasoning quality
5. **Decision point**: If Mistral meets 90%+ agreement + <5% citation errors → consider switch

---

## Cost-Benefit Analysis

### Current State (GPT-4o-mini)
- **Cost**: ~$42/year (quarterly runs)
- **Quality**: High (baseline)
- **Risk**: Low
- **Speed**: 20-30 minutes

### Switch to Mistral-7B
- **Cost**: $0/year
- **Quality**: ~85-90% of GPT-4o-mini (estimated)
- **Risk**: Medium (need validation)
- **Speed**: 8-12 hours
- **Savings**: ~$42/year

### Decision Framework
- **If quality validation passes** (90%+ agreement, <5% citation errors):
  - **Savings justify switch** if banking runs stay quarterly
  - **Speed trade-off acceptable** for quarterly runs
  - **Consider switch** if you want full control and consistency

- **If quality validation fails** (<90% agreement, >5% citation errors):
  - **Stay with GPT-4o-mini** - quality is more valuable than $42/year
  - **Revisit when** better local models available (Mistral 8x7B, Llama 3.1 70B)

---

## Conclusion

**Mistral-7B is likely capable** of performing banking tasks, but with **some quality trade-offs**:
- **Level 1 (Grading)**: Should work well (~85-90% accuracy) for most cases
- **Level 2 (Reasoning)**: May have more issues with citation accuracy and coherence

**The key question**: Is saving ~$42/year worth potential quality degradation and the need for validation infrastructure?

**Recommendation**: 
1. **Keep GPT-4o-mini** for now (low risk, proven quality)
2. **Build validation infrastructure** to test Mistral-7B in parallel
3. **Make decision based on data** (not assumptions)
4. **Revisit when** better local models become available or costs scale significantly

